reperfusion 发表于 2025-3-28 16:27:13

http://reply.papertrans.cn/47/4624/462302/462302_41.png

胰脏 发表于 2025-3-28 21:48:51

Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma,y to the successful development of immune checkpoint inhibitors in the treatment of recurrent/metastatic (R/M) NPC. Both EBV-targeting and non-EBV-targeting immunotherapeutic strategies have been evaluated in early phase clinical trials over the last two decades. Several phase II studies have report
页: 1 2 3 4 [5]
查看完整版本: Titlebook: Immunotherapy for Head and Neck Cancer; Anthony T. C. Chan,Brigette B.Y. Ma Book 2023 The Editor(s) (if applicable) and The Author(s), und